A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer.
about
Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancerVariable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugsPulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic CascadeGene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.Reversal of anchorage-independent multicellular spheroid into a monolayer mimics a metastatic model.Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrestNF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.Relevance of mortalin to cancer cell stemness and cancer therapy.Cancer therapy with trifunctional antibodies: linking innate and adaptive immunity.Lung cancer stem cells: tumor biology and clinical implications.Lung cancer stem cells and implications for future therapeutics.Potential use of glioblastoma tumorsphere: clinical credentialing.FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway.Zinc suppresses stem cell properties of lung cancer cells through protein kinase C-mediated β-catenin degradation.Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosisIron induces cancer stem cells and aggressive phenotypes in human lung cancer cells.Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells.Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells.Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumorsYM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling.Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells.The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis.NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.
P2860
Q28488566-C3943233-AFE9-48DB-A8CF-D02031A9A3EEQ34123603-B52A5BCF-4646-40C6-8694-139575043E0BQ34712278-6D798153-8DAD-4C27-BE67-B695A20FD36EQ35078001-01187E6D-FF08-40EE-AEE2-7052038AF04FQ35373200-85C7C131-B8FD-4795-BFA5-EFF065DD2C4BQ36546605-0409E703-7F6E-4916-9047-0B22D7F97A77Q36586535-E6004C90-564A-4A7B-AAB9-DD975131F82CQ37173070-EB24AE0A-A0B5-4C31-AEC7-650A684EDB54Q37625726-74F9A62C-9538-4C49-8DDF-DB85E1D4250BQ37965555-D3057A8B-96D9-4351-BDF1-018FE6345BE1Q38035056-B8C1357C-D9EB-4359-8A0D-585EF54C3860Q38189297-459AF686-CBF3-4BBD-BA8C-58908E8FF3C9Q38335033-0A31D928-A486-4A97-83C4-FFF2F55CADEFQ38598784-0364E59E-7E69-4E75-86B3-345B4A6551EEQ38703410-732B1991-0299-4411-A55C-86CFF2A91532Q38719437-0C737535-E67F-4FD5-BA00-6EE1DE6A4159Q38763356-259CD46D-570F-4A43-B1D9-B5EB265A09D8Q38791381-1C6B3FEA-B6B9-4E4F-9A4E-0BCCE79CCC23Q38939042-F1FFB968-68F4-45BA-A7DF-ABA9A9865796Q39029327-E30D3DC3-BFB1-4F5B-A857-F01EFF5748D1Q39098768-80C877C2-614D-4C1D-9D7C-7A1ED23D5029Q39424181-3E57BA22-3308-4F33-AD90-D307E2437411Q41281151-C4E34081-7F07-4D6C-BB00-2FEBE271C748Q41553115-60AFF6B5-8A8A-4199-AE87-A1DED05EF44FQ42013055-E934AE4D-A55C-448E-82F4-85175748D6F2Q45801884-3F445C6D-1E35-4EB5-A281-94702A34C3D7Q54982062-5A407E4F-F8F1-4C17-8358-31C06C63A411
P2860
A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role for cancer stem cells i ...... in non-small-cell lung cancer.
@en
A role for cancer stem cells i ...... in non-small-cell lung cancer.
@nl
type
label
A role for cancer stem cells i ...... in non-small-cell lung cancer.
@en
A role for cancer stem cells i ...... in non-small-cell lung cancer.
@nl
prefLabel
A role for cancer stem cells i ...... in non-small-cell lung cancer.
@en
A role for cancer stem cells i ...... in non-small-cell lung cancer.
@nl
P2093
P2860
P1476
A role for cancer stem cells i ...... in non-small-cell lung cancer
@en
P2093
Blanca D López-Ayllón
Javier de Castro Carpeño
Rosario Perona
P2860
P2888
P304
P356
10.1007/S12094-011-0656-3
P577
2011-05-01T00:00:00Z